GHealth News - GHealth News

Dec132020 by GHealth NewsNo Comments

Italy’s staggering virus toll poses uncomfortable questions

COVID19

ROME (AP) — Italy is reclaiming a record that nobody wants — the most coronavirus deaths in Europe — after the health care system again failed to protect the elderly and government authorities delayed imposing new restrictions. This wasn’t supposed to happen. Italy was the first country in the West to be slammed by COVID-19 and, after suffering a huge wave of death in spring, brought infections under control. Italy then had the benefit of time and experience heading into the fall resurgence because it trailed Spain, France and Germany in recording big new clusters of infections. Yet the virus spread fast and wide, and Italy has added nearly 29,000 dead since Sept. 1. Source: AP News

Latest Ebola outbreak in DR Congo is declared over, with lessons for COVID-19

Communicable Diseases

“This great achievement shows that together we can overcome any health challenge”, Dr. Tedros Adhanom Ghebreyesus, the WHO Director General, wrote in a tweet.  The outbreak in DRC’s northwestern Equateur Province emerged in early June and caused 130 Ebola cases and 55 deaths. Vaccinations key A key part of the response – with potential lessons for the global fight against COVID19 – was the vaccination of more than 40,000 people at high risk of falling sick from the frequently fatal haemorrhagic disease, the WHO said in a statement. Like one of the COVID-19 candidate vaccines, the Ebola vaccine needs to be kept at super-cold temperatures to keep it from spoiling. “Overcoming one of the world’s most dangerous pathogens in remote and hard to access communities demonstrat...

Pfizer’s Covid Vaccine: 11 Things You Need to Know

COVID19

Kena Betancur/Agence France-Presse — Getty Images By Carl Zimmer and Katie Thomas As coronavirus cases surge in the United States and elsewhere, with little relief in sight, the world got good news on Monday. Pfizer and its partner, the German company, BioNTech, announced preliminary results that suggested their vaccine was more than 90 percent effective. The news — the first results from any late-stage vaccine trial — buoyed stock markets and spirits as the public saw a glimmer of hope. But it’s worth noting that the news is still preliminary, and there is much that is still not known about how well the vaccine works. And one thing remained clear: The vaccine will not come in time to rescue the world from the next several months, when the virus will take many more lives unless...